Pfizer Moves Forward With Once-Daily Weight-Loss Pill
NEW YORK -- Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation for danuglipron, an oral…
Read More...
Read More...